Cyflumetofen induces hepatic steatosis and disrupts lipid metabolism in zebrafish larvae

Key Points

• Hepatic steatosis was induced in zebrafish larvae after exposure to cyflumetofen, indicating a significant alteration in lipid metabolism.
• Key evidence includes notable changes in lipid accumulation levels after cyflumetofen treatment over a specified period.
• The assessment involves an observational analysis of zebrafish larvae exposed to cyflumetofen, elucidating the compound's biochemical effects.
• Findings underscore the need for further studies to explore long-term implications of cyflumetofen exposure on aquatic life.